𝔖 Bobbio Scriptorium
✦   LIBER   ✦

First-pass evaluation of renal perfusion with turboflash MR imaging and superparamagnetic iron oxide particles

✍ Scribed by Hervë Trillaud; Nicolas Grenier; Philippe Degreze; Catherine Louail; Catherine Chambon; Jean-Michel Franconi


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
895 KB
Volume
3
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

First‐pass intrarenal hemodynamics were studied with superparamagnetic iron oxide particles and a T2‐weighted TurboFLASH (fast low‐angle shot) magnetic resonance (MR) imaging sequence. Four groups of five rabbits each were imaged after bolus injection of 40, 100, 140, and 200 μ,mol/kg iron, respectively. Images were acquired every 1.2 seconds, with an acquisition time of 700 msec. The signal intensity was measured in the cortex, outer medulla, inner medulla, and globally. In preliminary pathologic applications, two rabbits were imaged after ligation of the lumbar ureter and two after embolization of the renal artery. The reproducibil‐ity of the normal dynamics was evaluated with a cross‐correlation test. On the images, the intravas‐cular progression of the iron particles could be visualized within the cortex and the two compartments of the medulla in all cases. The maximal reduction in signal intensity in the cortex and medulla increased with the dose. The relationship between signal intensity decrease and dose was not linear, and the reproducibility of the signal intensity versus time plots was acceptable only at the 140 and 200 μ.mol/kg doses. The decrease in signal intensity was reduced and delayed in the emboli‐zed and hydronephrotic kidneys.


📜 SIMILAR VOLUMES


Contrast-enhanced MR imaging of liver an
✍ Bernd Hamm; Thomas Staks; Matthias Taupitz; Renate Maibauer; Andrea Speidel; Ale 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English

## Abstract The aim of this prospective study was to obtain the first human safety and magnetic resonance (MR) imaging results with a new formulation of superparamagnetic iron oxide (SPIO) (SHU 555 A). The SPIO was tested at four iron doses, from 5 to 40 μmol/kg. Laboratory tests and clinical measu